The use of cardiotonic drugs in neonates

Dempsey, Eugene; Rabe, Heike

The use of cardiotonic drugs in neonates

cbnd

Files

The Use of Cardiotonic Drugs in Neonates.pdf(960.34 KB)

Accepted Version

Date

2019

Authors

Dempsey, Eugene

Rabe, Heike

Publisher

W.B. Saunders

Published Version

https://doi.org/10.1016/j.clp.2019.02.010

Abstract

There is a distinct lack of age-appropriate cardiotonic drugs, and adult derived formulations continue to be administered, without evidence-based knowledge on their dosing, safety, efficacy, and long-term effects. Dopamine remains the most commonly studied and prescribed cardiotonic drug in the neonatal intensive care unit (NICU), but evidence of its effect on endorgan perfusion still remains. Unlike adult and pediatric critical care, there are significant gaps in our knowledge on the use of various cardiotonic drugs in various forms of circulatory failure in the NICU. © 2019 Elsevier Inc.

Keywords

Inodilator , Inotrope , Low blood pressure , Newborn , Shock , Vasopressor

Citation

Dempsey, E. and Rabe, H. (2019) 'The use of cardiotonic drugs in neonates', Clinics in Perinatology, 46(2), pp.273-290. https://doi.org/10.1016/j.clp.2019.02.010